ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/crisprbits” target=”_blank”>CrisprBits, a Bengaluru-based biotech startup, has developed a platform from CRISPR-based molecular diagnostics for early detection of ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/antibiotic-resistance” target=”_blank”>antibiotic resistance in hospital-acquired infections. The startup’s ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/pathcrisp-platform” target=”_blank”>PathCrisp platform can detect resistance in bacterial samples from patients within two hours compared to 24-27 hours through other methods. This can reduce prolonged hospital stays and bring down healthcare costs. “It operates at a constant temperature, eliminating the need for a thermocycler, and works directly on various samples, including…
